Pharma: Bafin checks Dermapharm's balance sheet for irregularities - shares fall sharply
⚡ Quick Summary
The drugmaker is said to have violated accounting rules in its annual financial statements for 2025, regulators said.
📰 Related Articles
DSW21 and BVB are expanding their KombiTicket partnership
DSW21
Surrogacy: Felix Banaszak accuses Jens Spahn of lacking integrity
Die Zeit
“Suddenly it stormed – we thought we were at war”
Die Welt
AfD: “Attempts at sabotage” – dispute over NRW-AfD comes to a head
Handelsblatt
Criticism of Spahn's paternity - CDU politician "personally shocked", Greens demand explanation
Die Welt